Stock hasn’t moved much lately, and the reason is we are doodling and dawdling in the doldrums of the market. We’ve had some corrections, and this one has not done too badly at all. This depends so much on the railcar industry, the timeliness of the needs to renew the railcars. They are developing products, they are selling, and they are expanding their plant in Texas. This is the beginning of things. You have to be patient. This could be his Top Pick.
To him, it is a very, very good speculative opportunity on Jonathan Goodman of Paladin Labs fame, a determined man who took Paladin to the $140 level. He is attempting to repeat this again. Has deep experience. The very important thing about this company is that it has this voucher, an FDA award, which enables a company to buy an acceleration of the FDA process. The only one left in the world.
This kind of collapsed in a mysterious way in July. Thinks it went too far, too fast. Wait for the recovery for the company to get its nose and head down and get working on the products, and selling into the US hospital space. Have new products and they are getting serious. Thinks it has now stabilized. Speculatively, it could easily double in the next 12 months.